Company Filing History:
Years Active: 2005-2014
Title: Sergey Gregory Wolfson: Innovator in Pharmaceutical Compounds
Introduction
Sergey Gregory Wolfson is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 3 patents to his name, Wolfson's work has garnered attention in the scientific community.
Latest Patents
Wolfson's latest patents include groundbreaking research on pyrrolo[2,3-D]pyrimidine compounds. These compounds are recognized for their potential use as Janus Kinase (JAK) inhibitors, which are crucial in treating various diseases. Additionally, he has developed a phenol derivative, specifically the compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol. This compound can be utilized to prepare another compound through a reaction with methyl bromide.
Career Highlights
Throughout his career, Wolfson has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Pharmacia & Upjohn Company. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Wolfson has collaborated with esteemed colleagues such as Ivan Richards and Sue K Cammarata. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.
Conclusion
Sergey Gregory Wolfson's contributions to pharmaceutical innovations are noteworthy. His patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the industry positively.